Academia-industry partnerships: are we ready for new models of partnership?: the point of view of the EORTC, an academic clinical cancer research organisation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1016/j.ejca.2012.09.027PMID 23079476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

  2012cited by this paper
• Overcoming regulatory and economic challenges facing pharmacogenomics.

  2012cited by this paper
• The unintended consequences of conflict of interest disclosure.

  2012cited by this paper
• Open Clinical Trial Data for All? A View from Regulators

  2012cited by this paper
• Public-private partnerships need honest brokering

  2012cited by this paper
• Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinoma.

  2011cited by this paper
• Vatalanib in advanced colorectal cancer: two studies with identical results.

  2011cited by this paper
• Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia.

  2011cited by this paper
• When Sunlight Fails to Disinfect: Understanding the Perverse Effects of Disclosing Conflicts of Interest

  2011cited by this paper
• Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.

  2011cited by this paper
• Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.

  2011cited by this paper
• Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.

  2010cited by this paper
• Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.

  2009cited by this paper
• Pharmaceutical company funding and its consequences: a qualitative systematic review.

  2008cited by this paper
• Relationship between conflicts of interest and research results

  2007cited by this paper
• Keeping faith with trial volunteers

  2007cited by this paper
• Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.

  2005cited by this paper
• Extent and impact of industry sponsorship conflicts of interest in dermatology research.

  2005cited by this paper
• The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest

  2005cited by this paper
• Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.

  2005cited by this paper
• Regulatory Perspectives on Data Safety Monitoring Boards

  2004cited by this paper
• Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

  2004cited by this paper
• Pharmaceutical industry sponsorship and research outcome and quality: systematic review

  2003cited by this paper
• Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

  2003cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper

• The anti-cancer effectiveness of some heterocyclic compounds containing sulfur atom

  2025cites this paper
• A call to rethink the necessity of and challenges facing academic research organizations in the new era of drug innovation in China.

  2024cites this paper
• Collaborative university-industry R&D practices supporting the pharmaceutical innovation process: insights from a bibliometric review.

  2022cites this paper
• Experiences in Academic and Industry Partnerships – Forging a Path to Translational Drug Discovery

  2021cites this paper
• A Proposed Model for the Academia-Industry Collaboration: A Case Study

  2021cites this paper
• Independent Research in Italy

  2020cites this paper
• Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

  2020cites this paper
• Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom: Langzeitergebnisse der ABCSG-8A-Studie

  2020cites this paper
• Beyond Academia: Examining the Versatile Career Paths of PhDs

  2020cites this paper
• Improving Clinical Trial Design in Gastrointestinal Oncology

  2019cites this paper
• The role of pharmacology in anticancer drug development

  2018cites this paper
• Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients

  2017cites this paper
• Structural and functional reorganization of propriospinal connections promotes functional recovery after spinal cord injury

  2017cites this paper
• How to increase the efficiency in research on non-surgical interventions during cancer surgery?

  2017cites this paper
• From bench to clinical trials the EORTC experience in biology-based clinical cancer research.

  2017cites this paper
• Editor's perspective: How rare is rare?

  2017cites this paper
• Precision Medicine: From “Omics” to Economics towards Data-Driven Healthcare - Time for European Transformation

  2017cites this paper
• Clinical Nurse Specialist Roles in Conducting Research: Changes Over 3 Years

  2016cites this paper
• Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives

  2016cites this paper
• Long-Term Consequences of Acute Inflammation in the Surgical Patient: New Findings and Perspectives

  2016cites this paper
• Methodology of clinical trials in lung cancer.

  2015cites this paper
• The changing world of drug development.

  2014cites this paper
• The 41st David A. Karnofsky Memorial Award Lecture: Academic research worldwide--quo vadis?

  2014cites this paper
• European perspective for effective cancer drug development

  2014cites this paper
• Does cilengitide deserve another chance?-Authors' reply.

  2014cites this paper
• Inflammation-Based Scores: A New Method for Patient-Targeted Strategies and Improved Perioperative Outcome in Cancer Patients

  2014cites this paper
• Perspectives in anaesthesia for cancer surgery

  2014influential citation
• Towards personalized medicine in the EU: what is needed to facilitate the complex international clinical research?

  2013cites this paper
• International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective

  2013cites this paper
• How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?

  2013cites this paper